FCGR2A and neoplasm: The presence of GZMB-positive T cells in tumor was confirmed by IHC in HSC4-, NCI-H1975-, or HCC827-engrafted huNOG-FcγR−/− mice after nivolumab treatment (Supplementary Fig. 18).